Ruth: Please stand by. Morning. My name is Ruth, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Fourth Quarter and Full Year 2025 Earnings ...
Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results